Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Income from Continuing Operations
Burning Rock Biotech Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Income from Continuing Operations
-¥653.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Income from Continuing Operations
-¥13.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Income from Continuing Operations
-¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Income from Continuing Operations
¥1.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Income from Continuing Operations
¥8.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Income from Continuing Operations
¥1.3B
|
CAGR 3-Years
62%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Income from Continuing Operations?
Income from Continuing Operations
-653.7m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Income from Continuing Operations amounts to -653.7m CNY.
What is Burning Rock Biotech Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-30%
Over the last year, the Income from Continuing Operations growth was 33%. The average annual Income from Continuing Operations growth rates for Burning Rock Biotech Ltd have been -17% over the past three years , -30% over the past five years .